Medical Oncology: Chemotherapy, targeted therapies, and combination regimens.

Medical oncology continues to evolve with advancements in chemotherapy, targeted therapies, and combination regimens. Case studies often focus on individualized treatment plans based on genetic and molecular tumor profiling, such as using EGFR inhibitors for non-small cell lung cancer. Combination regimens, like adding bevacizumab to chemotherapy, demonstrate enhanced efficacy for certain cancers. Additionally, the use of maintenance therapies prolongs progression-free survival in metastatic cases. These developments underscore the critical role of medical oncology in providing systemic treatments that complement surgical and radiation approaches, ensuring comprehensive cancer care tailored to each patient’s needs.